New research shows that resident heart macrophages and fibroblasts create specialized "driver regions" that help sustain persistent atrial fibrillation, offering a new target for personalized ablation therapy
Most Recent Articles
Reducing Localization Error in Electrophysiology via Global Volumetric Mapping
New volumetric mapping technology allows doctors to see inside the heart walls non-invasively, reducing arrhythmia localization errors by nearly 60% to improve cardiac ablation accuracy.
Optimizing Structural Heart Disease Screening via Longitudinal EHR Pattern Recognition
The new TARGET-AI framework helps clinicians decide exactly when to use AI heart screening tools by analyzing patient records to predict who will benefit most from advanced testing.
Integrated Sleep Assessment as a Standard for Cardiovascular Risk Stratification
Veterans with both insomnia and sleep apnea face a much higher risk of heart disease than those with only one condition, highlighting the need for integrated sleep therapy.
Beyond Neutralization: The Role of Afucosylated IgG in Tuberculosis Protection
New research reveals that antibodies with specific sugar signatures can activate immune cells to block the replication of tuberculosis-causing bacteria, opening doors for more effective vaccines and treatments.